Numerous tumor types have been shown to utilize increased MCL1 expression to promote survival, including multiple myeloma, small cell lung cancer, and others, suggesting MCL1 could also confer a survival advantage to metastatic osteosarcoma cells in the hostile lung environment [34–36]. Here, MCL1 is linked to neoplasm.